Kristen Oelschlager Insider Trades & Stock Holdings

Chief Operating Officer · Castle Biosciences, Inc. · Latest filing Jun 16, 2026

Kristen Oelschlager, Chief Operating Officer at Castle Biosciences, Inc. has 1 Form 4 trade on file since Jun 16, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($177.84K), net -$177.84K. Latest filing: disposed of 8.59K shares of $CSTL on Jun 16, 2026 at $20.71.

Trades on file

1

Open-market bought

$0

Open-market sold

$177.84K

Net open-market

-$177.84K

Latest filing

Jun 16, 2026

All insider trades by Kristen Oelschlager

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Jun 16, 2026	$CSTL	Sell (Open-market sale) 10b5-1	8.59K	$20.71	$177.84K			+4.5%	+18.4%		Chief Operating Officer		Read

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Kristen Oelschlager traded

• $CSTL

Frequently asked questions

Has Kristen Oelschlager been buying or selling stock?

Kristen Oelschlager has 0 open-market purchases and 1 open-market sale on file, net -$177.84K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Kristen Oelschlager's latest insider trade?

disposed of 8.59K shares of $CSTL on Jun 16, 2026 at $20.71.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.